Back to Self-Funded Mastery

Published: 2026-08-19

High-Cost Claimants: The Line Item You Need to Manage Early

Wellmark frames this issue in a useful way. Wellmark discusses managing high-cost claimants and the importance of early attention.

For employers, the value is not the definition. The value is what the definition changes before the company signs another renewal.

A serious claim needs care support, privacy, vendor coordination, and financial planning. Treating it like a spreadsheet line item is both cold and ineffective.

Why This Matters To The Business

One employee gets a diagnosis. The plan sees a large claim. Leadership should see a person who needs the system to work.

That moment shows the real problem. The plan may be expensive, but the bigger issue is often that nobody can explain the machinery underneath it.

For the CEO, this connects to margin, hiring, retention, and risk. Ask whether the plan helps people navigate care before costs explode.

For the CFO, this connects to cash flow and control. Ask how large claimants are identified, supported, protected, and reflected in stop-loss renewal.

The Practical Review

Put the current plan, contract, or renewal proposal on the table. Then ask:

Do not accept a vague answer. Do not accept a slide that looks good but leaves the decision unclear. Ask for the document, the number, and the person who owns the next step.

What Good Looks Like

Claims data is only valuable when it changes action. A report that arrives late, lacks detail, or never reaches leadership is just historical noise.

The CFO needs trend, high-cost risk, pharmacy movement, stop-loss impact, and the next decision tied to each finding.

What I would want in the file:

That file does two jobs. It helps leadership make a better decision now. It also creates a record that shows the company acted with care later.

This is the gap I see most often. The employer may have a smart person in HR, a broker presentation, and a spreadsheet. But nobody has a clean decision file. When pressure hits, the company has memories instead of proof.

The practical goal is not to sound sophisticated. The goal is to make the next decision easier to defend. If a CEO or CFO cannot explain the choice in plain English, the company is not ready to sign.

What To Do Before Renewal

Review case management, specialty drug support, centers of excellence, privacy rules, and escalation paths.

This is where proactive strategy beats reactive shopping. Renewal season should not be the first time leadership sees the risk. It should be the point where a prepared team confirms the path.

The Warning Sign

Do not let cost management become care neglect.

That warning sign is not small. It tells you whether the plan is governed or merely renewed.

Save this line: High-cost claimants are people first.

The rules are changing. The exposure is real. The opportunity is massive for employers that move early.

Book 15 minutes at www.Paul.Health if you want this reviewed against your current plan.